NCT03123068View on ClinicalTrials.gov

Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

December 14, 2018

Study Completion Date

December 14, 2018

Conditions
Surgical Recovery
Interventions
DRUG

CocoaVia®

CocoaVia® is manufactured by Mars, Inc. It is a dietary supplement of cocoa bean extract, containing 125 mg cocoa flavanols per capsule.

OTHER

Placebo

The placebo capsules will contain an inert ingredient packaged to be indistinguishable from the active treatment.

Trial Locations (1)

94305

Stanford University Hospital, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03123068 - Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery | Biotech Hunter | Biotech Hunter